Cao Sean Wuxiong sold 107,978 NovaBridge Biosciences shares at $0.74 per share on Sep 9, 2026. For investors, the reported ownership outcome is that Wuxiong retained 266,467 shares after the sale, while the transaction represented about 28.8% of his prior shares holding.
Key Highlights
- Cao Sean Wuxiong is NovaBridge Biosciences’ Chief Business Development Officer.
- The transaction carried code S.
- NovaBridge Biosciences is listed on Nasdaq under NBP.
NovaBridge Biosciences (NASDAQ: NBP) officer Cao Sean Wuxiong sold 107,978 shares at $0.74 per share on Sep 9, 2026. The transaction represented about 28.8% of his prior shares holding, leaving him with 266,467 shares.
Transaction Details
Cao Sean Wuxiong, NovaBridge Biosciences’ Chief Business Development Officer, completed the sale at $0.74 per share. The transaction quantity was 107,978 shares of NovaBridge Biosciences. It carried transaction code S. NovaBridge Biosciences is listed on Nasdaq under NBP. Wuxiong was identified as an officer of NovaBridge Biosciences.
Post-Sale Holding Stands at 266,467 Shares
Wuxiong’s reported NovaBridge Biosciences holding stood at 266,467 shares after the transaction. The 28.8% figure is stated as an approximate share of his prior holding. The post-transaction balance is expressed in shares, while the percentage uses the earlier holding as its reference point.
FAQs
Q: How many NovaBridge Biosciences shares did Cao Sean Wuxiong sell?
A: Cao Sean Wuxiong sold 107,978 NovaBridge Biosciences shares at $0.74 per share on Sep 9, 2026. The transaction used code S.
Q: What was the impact of the NovaBridge Biosciences insider sale?
A: The filing reports that the transaction represented about 28.8% of Wuxiong’s prior shares holding. It also reports that his post-sale position was 266,467 NovaBridge Biosciences shares.
Q: How many NBP shares does Cao Sean Wuxiong own after the sale?
A: Cao Sean Wuxiong owned 266,467 NovaBridge Biosciences shares after selling 107,978 shares. The reported sale price was $0.74 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.